Investor Backing & Capital Strength:
A recent $100M Series C following prior rounds brings total funding to about $215M, indicating strong capacity to scale. A 2025 valuation milestone around $1B reinforces sustained investor confidence.
Strong Revenue Growth:
Revenue reportedly reached $111.9M in 2024 with consistent year-over-year increases since launch. Company communications describe continued momentum into 2025–2026.
Market Expansion:
The clinical network expanded rapidly to thousands of W‑2 dietitians across all 50 states and a broader pool cited at 10,000+ RDs, enabling nationwide access. Partnerships with hundreds of health plans covering over 200 million Americans and completion of millions of appointments signal widening reach.
